Brian Mueller

CEO

CFO CEO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Biomarin Pharmaceutical Inc (BMRN)	Executive Vice President, CFO	$721,154	—	$4,329,063	$1,193,203	$565,500	$22,892	$6,831,812
2024	Biomarin Pharmaceutical Inc (BMRN)	Executive Vice President, CFO	$699,231	—	$3,199,820	$963,369	$613,350	$22,798	$5,498,568
2023	Biomarin Pharmaceutical Inc (BMRN)	Executive Vice President, CFO	$666,346	—	$2,947,369	$832,004	$384,750	$23,723	$4,854,192
2022	Biomarin Pharmaceutical Inc (BMRN)	Executive Vice President, CFO	$624,231	—	$3,104,558	$852,883	$500,850	$24,762	$5,107,284
2021	Biomarin Pharmaceutical Inc (BMRN)	Executive Vice President, Finance and CFO	$600,000	—	$2,773,957	$793,742	$511,500	$19,966	$4,699,165
2020	Biomarin Pharmaceutical Inc (BMRN)	Executive Vice President, Finance and CFO	$600,923	—	$4,009,685	$845,333	$363,000	$21,590	$5,840,531
2019	Grand Canyon Education, Inc. (LOPE)	Chief Executive Officer and Chairman (Principal Executive Officer)	$321,000	—	$1,211,502	—	$392,454	$4,130	$1,929,086
2019	Biomarin Pharmaceutical Inc (BMRN)	Executive Vice President, Finance and CFO	$417,235	—	$546,383	$356,857	$336,000	$20,061	$1,676,536
2018	Grand Canyon Education, Inc. (LOPE)	Chief Executive Officer and Chairman (Principal Executive Officer)	$487,673	—	$1,230,040	—	$637,988	$5,494	$2,361,195
2018	Biomarin Pharmaceutical Inc (BMRN)	Executive Vice President and Chief Financial Officer Daniel Spiegelman Former Executive Vice President, Chief Financial Officer	$402,712	—	$477,185	$305,155	$320,000	$19,633	$1,524,685
2017	Grand Canyon Education, Inc. (LOPE)	Chief Executive Officer and Chairman (Principal Executive Officer)	$642,000	—	$1,249,916	—	$904,434	$3,564	$2,799,914

Earnings-call appearances

Canaccord Genuity 46th Annual Growth Conference
Biomarin Pharmaceutical Inc (BMRN)

2026-08-12
BioMarin Pharmaceutical Second Quarter 2026 Conference Call
Biomarin Pharmaceutical Inc (BMRN)

2026-08-06
Biomarin Pharmaceutical Inc Q1 FY2026 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2026-05-04
Grand Canyon Education, Inc. Q1 FY2026 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2026-04-30
Biomarin Pharmaceutical Inc Q4 FY2025 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2026-02-23
Grand Canyon Education, Inc. Q4 FY2025 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2026-02-18
Grand Canyon Education, Inc. Q3 FY2025 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2025-11-05
Biomarin Pharmaceutical Inc Q3 FY2025 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2025-10-27
Grand Canyon Education, Inc. Q2 FY2025 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2025-08-06
Biomarin Pharmaceutical Inc Q2 FY2025 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2025-08-04
Biomarin Pharmaceutical Inc Q1 FY2025 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2025-05-16
Grand Canyon Education, Inc. Q1 FY2025 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2025-05-06
Biomarin Pharmaceutical Inc Q4 FY2024 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2025-02-19
Grand Canyon Education, Inc. Q4 FY2024 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2025-02-19
Grand Canyon Education, Inc. Q3 FY2024 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2024-11-06
Biomarin Pharmaceutical Inc Q3 FY2024 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2024-10-29
Grand Canyon Education, Inc. Q2 FY2024 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2024-08-06
Biomarin Pharmaceutical Inc Q2 FY2024 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2024-08-05
Grand Canyon Education, Inc. Q1 FY2024 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2024-05-07
Biomarin Pharmaceutical Inc Q1 FY2024 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2024-04-24
Biomarin Pharmaceutical Inc Q4 FY2023 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2024-02-22
Grand Canyon Education, Inc. Q4 FY2023 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2024-02-13
Grand Canyon Education, Inc. Q3 FY2023 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2023-11-02
Biomarin Pharmaceutical Inc Q3 FY2023 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2023-11-01
Grand Canyon Education, Inc. Q2 FY2023 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2023-08-03
Biomarin Pharmaceutical Inc Q2 FY2023 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2023-07-31
Grand Canyon Education, Inc. Q1 FY2023 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2023-05-02
Biomarin Pharmaceutical Inc Q1 FY2023 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2023-04-26
Biomarin Pharmaceutical Inc Q4 FY2022 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2023-02-27
Grand Canyon Education, Inc. Q4 FY2022 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2023-02-16
Grand Canyon Education, Inc. Q3 FY2022 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2022-10-27
Biomarin Pharmaceutical Inc Q3 FY2022 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2022-10-26
Biomarin Pharmaceutical Inc Q2 FY2022 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2022-08-25
Grand Canyon Education, Inc. Q2 FY2022 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2022-08-04
Grand Canyon Education, Inc. Q1 FY2022 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2022-05-04
Biomarin Pharmaceutical Inc Q1 FY2022 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2022-04-27
Biomarin Pharmaceutical Inc Q4 FY2021 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2022-02-23
Grand Canyon Education, Inc. Q4 FY2021 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2022-02-16
Grand Canyon Education, Inc. Q3 FY2021 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2021-10-28
Biomarin Pharmaceutical Inc Q3 FY2021 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2021-10-27
Grand Canyon Education, Inc. Q2 FY2021 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2021-08-05
Biomarin Pharmaceutical Inc Q2 FY2021 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2021-07-28
Grand Canyon Education, Inc. Q1 FY2021 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2021-05-05
Biomarin Pharmaceutical Inc Q1 FY2021 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2021-04-29
Biomarin Pharmaceutical Inc Q4 FY2020 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2021-02-25
Grand Canyon Education, Inc. Q4 FY2020 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2021-02-17
Grand Canyon Education, Inc. Q3 FY2020 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2020-11-05
Biomarin Pharmaceutical Inc Q3 FY2020 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2020-11-05
Biomarin Pharmaceutical Inc Q2 FY2020 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2020-08-04
Grand Canyon Education, Inc. Q2 FY2020 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2020-08-04
Grand Canyon Education, Inc. Q1 FY2020 Earnings Call
Grand Canyon Education, Inc. (LOPE)

2020-05-07
Biomarin Pharmaceutical Inc Q1 FY2020 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2020-04-29